{"id":"W2943665137","doi":"10.1186/s40425-019-0578-0","title":"Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Dental and Craniofacial Research","keywords":"Medicine; Cetuximab; Nivolumab; Pembrolizumab; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Docetaxel; Clinical trial; Immunotherapy; Head and neck cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01248521,0.0008163864,0.001755741,0.0006116151,0.0002150164,0.001178101,0.000715601,0.00113913,0.004137051],"category_scores_gemma":[0.01198469,0.0002867105,0.004805888,0.000998072,0.0005031972,0.0007904408,0.0005839301,0.001408578,0.0004102267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000736683,"about_ca_system_score_gemma":0.0009351421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002984261,"about_ca_topic_score_gemma":0.0007717866,"domain_scores_codex":[0.9937797,0.003912725,0.0005558409,0.0008626407,0.0005317355,0.0003574109],"domain_scores_gemma":[0.9864011,0.006527228,0.003556639,0.001819655,0.0007431568,0.0009520997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7938236,0.00479791,0.04578976,0.003644082,0.04446996,0.0002269594,0.0001681112,0.007862444,0.0190693,0.001616113,0.005139078,0.07339267],"study_design_scores_gemma":[0.1937875,0.4218678,0.2955543,0.0003174038,0.03957049,0.001104495,0.0001925396,0.008545484,0.01414017,0.001949843,0.02276485,0.0002052061],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.97244,0.01318661,0.002458821,0.0003950536,0.000217473,0.001210881,0.006280762,0.00007642483,0.003733911],"genre_scores_gemma":[0.9882995,0.001396932,0.001617879,0.0005292551,0.0001140367,0.000687306,0.006297669,0.000023436,0.001033994],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01248521,"threshold_uncertainty_score":0.06602889,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06821629106114331,"score_gpt":0.4354250672816484,"score_spread":0.3672087762205051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}